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A B S T R A C T
Genetic epidemiology studies of hereditary hemochromatosis (HHC) have shown a high prevalence of the C282Y mu-
tation in individuals of the North Western European origin, whereas lower prevalence of HFE gene mutations was de-
tected in the populations from southern European countries. However, no HFE mutation prevalence data have been pro-
vided for the population of Bosnia-Herzegovina so far. Therefore, the aim of this study was to determine the frequency of
the C282Y and H63D HFE gene mutations in the population of Bosnia-Herzegovina. Among 200 analysed subjects 8
(4%) were C282Y heterozygotes; no C282Y homozygotes were found. The frequency of the H63D allele was 11.5%. There
were 33 (16.5%) heterozygotes and 6 (3%) homozygotes for the H63D mutation. One (0.5%) compound heterozygote
C282Y/H63D was identified. The observed C282Y and H63D allele frequency was 2.25% (95% confidence interval:
1.2–4.2) and 11.5% (95% confidence interval: 8.7–14.9), respectively. The prevalence of the C282Y and H63D mutations
was estimated in Bosnia-Herzegovina, which fit well in the European northwest-to-southeast gradient of the C282Y mu-
tation distribution. In addition, these results have an important implication for clinical evaluation of HHC in Bosnia-
Herzegovina.
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Introduction
Hereditary hemochromatosis (HHC) is one of the
most common autosomal recessive inherited diseases in
Caucasians with an estimated prevalence of 1:188 to
1:3271. In Caucasians the disease leads to progressive
iron accumulation in various organs (liver, pancreas,
heart and joints) with reduced lifetime-expectancy if
phlebotomy treatment is not instituted2.
The hemochromatosis gene (HFE) was identified by
positional cloning and located on chromosome 6. Two
most frequent missense mutations were identified, na-
mely a G to A transition at nucleotide 845 which leads to
a substitution of cysteine for tyrosine mutation at the
amino acid position 282 (C282Y) and a C to G change at
nucleotide 187 that results in a substitution of histidine
for aspartate at the amino acid position 63 (H63D)3. Over
80% of HHC patients from North European populations
are homozygous for the C282Y mutation. A significant
proportion of HHC patients who are not homozygous for
C282Y are C282Y heterozygotes, compound heterozy-
gotes, H63D homozygotes, or H63D heterozygotes4. He-
reditary hemochromatosis was initially described exclu-
sively in individuals of the North Western European ori-
gin, whereas lower HFE gene mutations were detected in
populations from southern Europe5–9. However, no HFE
mutation prevalence data have been reported on the
Bosnia-Herzegovina population so far.
Therefore, the aim of this study was to determine the
frequency of C282Y and H63D HFE gene mutations in
the Bosnia-Herzegovina population.
Participants and Methods
The study population included two hundred (100 ma-
les and 100 females) unrelated healthy blood donors
from Bosnia and Herzegovina, in the period from 2003 to
2005. All participants subscribed the informed written
consent.
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Genomic DNA was extracted from peripheral blood
leukocytes using a standard procedure10. HFE mutation
analysis was performed using PCR-RFLP analysis, as
previously described11. The amplified PCR fragments
were digested with restriction enzyme Rsa I to identify
the C282Y mutation and with Mbo I to detect the H63D
mutation, as recommended by the manufacturer (Pro-
mega, USA). Restriction enzyme digest products were
analysed on a 3.0% agarose gel and visualized after ethi-
dium bromide staining.
Chi-squared (2) test was used to compare the fre-
quency of C282Y and H63D genotypes. A 95% confidence
interval (CI) was calculated for the frequency of the al-
leles.
Results
Frequencies of the C282Y and H63D genotypes are
shown in Table 1. Among 200 analysed subjects 8 (4%)
were C282Y heterozygotes, 33 (16.5%) were H63D het-
erozygotes and 6 (3%) were homozygotes for the H63D
mutation. One (0.5%) compound heterozygote C282Y/
H63D was identified and no C282Y homozygotes were
found.
The genotype distribution of C282Y was within Har-
dy-Weinberg equilibrium (p=0.74; 2=0.11), whereas the
H63D distribution was not (p=0.02; 2=5.43).
In Table 2, the allelic frequencies of the two muta-
tions are presented. The overall C282Y allele frequency
in the population of Bosnia-Herzegovina population was
2.25% (95% CI: 1.2–4.2) and the observed H63D allele
frequency was 11.5% (95% CI: 8.7–14.9). Taking into ac-
count the allele frequency of C282Y, the prevalence of ho-
mozygous C282Y was calculated as approximately 0.5
per 1000.
Discussion
Hereditary hemochromatosis HFE mutations have
been studied in several European populations. Initially
HFE mutations were described exclusivelly in popula-
tions of North Western European origin12. It has been
suggested that the C282Y mutation originates within the
population of Celtic origin. On the other hand, there is
evidence that the C282Y mutation originated from the
Germanic Iron Age population in Southern Scandinavia
and spread with the Vikings13. The allele frequencies are
lowest in locations where the Vikings had been scarce
such as Central Europe, the Balkans and the Mediterra-
nean countries. As previously described, the frequency of
the C282Y mutation declines from Northern to Southern
Europe, thus allele frequencies of 6.5 to 8.2% was found
in English blood donors14, intermediate allele frequen-
cies (3.1–4.8%) are seen in the populations in Central
Europe4, whereas low allele frequencies (0–3.1%) are rec-
ognized in populations in Southern Europe and the Me-
diterranean6. According to the geographic position in Eu-
rope, the prevalence of the C282Y mutation in Bosnia
and Herzegovina (2.25%) fits in the observed north/
south gradient. Recent studies have shown that in Slo-
venia the observed allele frequency of the C282Y muta-
tion is 4.0%, in Croatia 3.3%, and in Greece 1.0%, which
is comparable to the frequencies found in the Bosnia-
-Herzegovina population9,15.
In the Bosnia-Herzegovina population, the H63D al-
lele frequency is 11.5%. This frequency is comparable to
European populations, in which the H63D mutation is
present, and is more frequent than C282Y, ranging be-
tween 10% and 20%4. In the Slovenian and Croatian pop-
ulations, the estimated prevalence of H63D is 14.5% and
declines to Middle East where it is between 8% and
10%4,9. There is a moderate deviation from Hardy-Win-
berg equilibrium in the distribution of H63D genotypes,
which might be explained as a consequence of genetic
drift and/or migrational movements in the area of Bosnia
and Herzegovina in the war and post-war period.
In conclusion, the estimated prevalence of the C282Y
and H63D mutations in the Bosnia-Herzegovina popula-
tion was lower than that in the Slovenian and Croatian
populations, which supports the idea of the so-called gra-
dient distribution of the C282Y mutation; a more defi-
nite proof on the origin of this mutation remains unclear.
These results have an important implication to clinical
evaluation of HHC in Bosnia and Herzegovina, and con-
tribute to an easy identification of those at risk of devel-
oping the disease.
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TABLE 1
DISTRIBUTION OF HFE GENOTYPES IN BOSNIA-HERZEGOVINA
C282Y H63D N = 200 %
–/– –/– 152 76.0
+/– –/– 8 4.0
+/+ –/– 0 0
–/– +/– 33 16.5
+/– +/– 1 0.5
+/+ +/– 0 0
–/– +/+ 6 3.0
+/– +/+ 0 0
+/+ +/+ 0 0
+ denotes the mutated allele, – denotes wild-type allele
TABLE 2
ALLELE FREQUENCIES AND 95% CONFIDENCE INTERVAL (CI)
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FREKVENCIJA C282Y I H63D MUTACIJA GENA HFE U BOSNI I HERCEGOVINI
S A @ E T A K
Geneti~ko-epidemiolo{ka istra`ivanja nasljedne hemokromatoze (HHC, hereditary hemochromatosis) pokazala su
visoku u~estalost mutacije C282Y kod osoba porijeklom iz sjeverozapadne Europe, dok je ni`a u~estalost mutacija HFE
gena opa`ena u populacijama ju`noeuropskih zemalja. Me|utim, do sada nisu postojali podaci o u~estalosti mutacija tog
gena za populaciju Bosne i Hercegovine. Zbog toga je cilj ovog istra`ivanja bio odrediti frekvenciju mutacija C282Y i
H63D HFE gena u populaciji Bosne i Hercegovine. Me|u 200 analiziranih ispitanika bilo je 8 (4%) C282Y heterozigota i
niti jedan C282Y homozigot. Frekvencija alela H63D bila je 11.5%. Zabilje`ena su 33 (16.5%) heterozigota i 6 (3%) ho-
mozigota za H63D mutaciju. Zabilje`en je 1 (0.5%) slo`eni heterozigot C282Y/H63D. Opa`ene frekvencije alela C282Y i
H63D bile su 2.25% (95%-tni interval pouzdanosti: 1.2–4.2) i 11.5% (95%-tni interval pouzdanosti: 8.7–14.9). Procije-
njena u~estalost mutacija C282Y i H63D u Bosni i Hercegovini dobro se uklapa u europski gradijent distribucije mu-
tacije C282Y od sjeverozapada prema jugoistoku. Uz to, ovi rezultati imaju va`nu ulogu za klini~ku evaluaciju HHC-a u
Bosni i Hercegovini.
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